Abstract
The article presents an overview of NEPTUNO’s own survey and research on the pharmacoeconomic analysis of the use of the polypill strategy.
 In the NEPTUNO study, it was shown that the use of a cardiovascular polypill containing acetylsalicylic acid, ramipril, atorvastatin (CNIC-Polypill – Trinomy) resulted in significantly lower use of health care resources compared to control groups; significantly lower total and direct medical costs. And this, in turn, led to a decrease in hospitalizations, cardiovascular events and the number of visits to the doctor.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
